3
项与 Anti-PSMA Designer T Cells(Roger Williams Medical Center) 相关的临床试验Phase II/Pilot Trial of Second Generation Designer T Cells in Colorectal Cancer
The purpose of this study is to collect data on the safety and effectiveness of 2nd generation designer T cells in patients with colorectal cancer. Designer T cells are prepared by collecting white blood cells from the participant, and then modifying these cells in the laboratory so that they recognize the tumor antigen (CEA). These modified cells are then given back into the participant so that they can attack and kill tumor cells.
Phase Ia/Ib Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
The purpose of this study is to collect data on the safety and effectiveness of 2nd generation designer T cells in patients with breast cancer. Designer T cells are prepared by collecting white blood cells from the participant, and then modifying these cells in the laboratory so that they recognize the tumor antigen (CEA). These modified cells are then given back to the participant so that they can attack and kill tumor cells.
Phase Ia/Ib Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
This study tests the safety and tolerability of autologous anti-PSMA gene-modified T cells (designer T cells) in hormone refractory prostate cancer.
100 项与 Anti-PSMA Designer T Cells(Roger Williams Medical Center) 相关的临床结果
100 项与 Anti-PSMA Designer T Cells(Roger Williams Medical Center) 相关的转化医学
100 项与 Anti-PSMA Designer T Cells(Roger Williams Medical Center) 相关的专利(医药)
100 项与 Anti-PSMA Designer T Cells(Roger Williams Medical Center) 相关的药物交易